Introduction
Over 2 million units of red cells are transfused in the UK every year, half of which are used for surgical patients. A successful transfusion is the appropriate provision of blood cells or other blood components in a safe and timely manner. This article gives a practical guide to transfusion medicine.
Blood groups
The most important blood group is the ABO system because of the natural expression of antibodies to A and B in individuals who do not have these antigens (Table  1) . If an individual receives cells with antigens recognized by the recipients' antibodies (e.g. group B recipient receiving group A red cells) these donor cells are identified as foreign and attacked, resulting in a severe haemolytic transfusion reaction.
Donor selection
Stringent criteria are in place to limit the chance of a donor with a transmissible infection giving blood. Each unit is screened for evidence of infection with syphilis, hepatitis B and C, the human immunodeficiency virus (HIV) 1 and 2, human T-cell lymphotropic viruses 1 and 2 and in some instances cytomegalovirus, malaria, West Nile virus and Trypanosoma cruzi.
Ordering blood: the practicalities
As severe reactions result from human error, great care must be taken to ensure the correct blood reaches the right patient, including labelling of blood samples sent to the laboratory. A group and save involves determining the patient's ABO blood group and screening serum for the presence of antibodies to common red cell antigens that can cause transfusion reactions.
In addition to this, crossmatching involves the mixing of samples from donor blood units with the patient's blood to see if any abnormal reaction occurs. A group and save should be ordered if the patient is unlikely to need a blood transfusion but it will reduce the time required for crossmatched blood, should the patient subsequently need it. If the patient needs blood, you should crossmatch the number of units they will need. As a general rule, one unit of blood raises the haemoglobin by 1 g/dl in the non-bleeding adult patient.
For elective surgery, the case should be discussed with the anaesthetist and surgeon, who will take into account the preoperative haemoglobin, the likely blood loss and the patient's tolerance for anaemia. In an emergency, liaise with the transfusion laboratory early: each hospital will have its own policy for crossmatching and treatment of major haemorrhage ( Table 2) .
As there are more than 12 blood group systems (e.g. ABO, Rhesus, Kell, Duffy Kidd, Diego MNS) it takes about 40 minutes to determine an individual's blood group (group and save) and 40 minutes to crossmatch (issue) blood. This may take Blood transfusion: a practical guide longer for people with rarer blood groups, people who have received many transfusions or who have developed antibodies. In emergencies ABO-group specific blood (12 minutes to issue) or group O blood (which has neither A nor B antigens) may be necessary.
Blood components, indications and guidelines
All blood components produced in the UK are filtered to remove white cells.
Whole blood
This is very rarely used.
Red cells
Each 250-350 ml bag has a haematocrit (% of cells) of 0.6. There are no platelets, very few white cells and 2,3-diphospoglycerate (2,3 DPG) levels remain normal for up to 14 days, allowing relatively normal oxygen uptake and release by haemoglobin. Red cell preparations may be stored for 42 days with SAGM (saline, adenine, glucose, mannitol) solution at 40°C but must be used within 6 hours at room temperature. Current guidelines suggest a haemoglobin transfusion threshold in stable patients of 8 g/dl, or 10 g/dl in patients with cardiorespiratory disease.
Platelets
In the UK, platelets either come from pooling of the platelet component from four units of whole donated blood, called random donor platelets, or by plasmapharesis from a single donor. The platelets are suspended in 200-300 ml of plasma and may be stored for up to 4 days in the transfusion laboratory where they are continually agitated at 22°C to preserve function. One adult platelet pool raises the normal platelet Table 3) . ABO identical or compatible platelets are preferred but not necessary in adults; but rhesus compatibility is required in recipients who are children and women of childbearing age to prevent haemolytic disease of the newborn.
Fresh frozen plasma
Fresh frozen plasma (FFP) is produced from centrifugation of whole donated blood, or plasmapheresis. Each 150 ml bag contains all clotting factors, albumin and antibodies. FFP must be used immediately after thawing and must be ABO compatible. The usual starting dose is 10-15 ml/kg, equivalent to three or four packs of FFP for a 70 kg person ( Table 4) . Because of the potential risk of variant Creutzfeldt-Jakob disease (vCJD) in UK donors, FFP for children born after 1995 is derived from unpaid USA donors.
Cryoprecipitate
Cryoprecipitate is precipitated from FFP, and contains high levels of factor VIII, fibrinogen and von Willebrand factor. Each unit contains 20-40 ml (although larger bags may be available) and should be ABO compatible with the patient. The main indication for cryoprecipitate is hypofibrinogenaemia, either as a result of massive transfusion or disseminated intravascular coagulation (DIC). Treatment is considered if the plasma fibrinogen is <0.8-1 g/ litre; ten units of cryoprecipitate should increase fibrinogen level by 1 g/litre.
Hazards of transfusion

Acute hazards
Serious or life-threatening reactions to transfusion are very rare. However, new symptoms or signs that arise during a transfusion must be taken seriously. Over half of serious transfusion reactions are caused by administrative errors: patients being transfused blood that had been intended for another patient. Other common acute effects include less severe immune reactions, fluid overload, transfusion associated lung injury (TRALI), and transfusion of bacterially infected components.
Severe immune transfusion reactions
This includes acute haemolytic transfusion reactions (such as ABO incompatibility) and immune reactions to other blood components such as platelets and white cells. ABO incompatibility can destroy red cells in the circulation, cause circulatory and respiratory collapse, initiate acute renal failure and cause DIC. It has been suggested that a single practitioner taking overall responsibility for checking the blood and patient before transfusion is safer than two practitioners checking. If red cells are mistakenly administered to the wrong patient, the chance of ABO incompatibility is about 1 in 3. Even a few drops of ABO incompatible blood may cause local symptoms within seconds, which is why patients should be closely observed at the start of each transfusion (Tables 5 and 6 ).
Since it may be impossible to identify immediately the cause of a severe reaction, the initial management is supportive.
Bacterial contamination of blood components
This is the commonest infective hazard of blood component transfusion. Clinically it causes a rapid onset of sepis: fever, tachycardia, hypotension, rigors and collapse.
Transfusion-related acute lung injury
TRALI is related to the presence of antibodies in donor plasma to the recipient's leucocytes. It is most common in individuals who have had large doses of FFP. Clinically, transfusion is followed by rapid onset of hypoxia, respiratory difficulties and a non-productive cough. The chest Xray characteristically shows bilateral infiltrates. The treatment is that for adult respiratory distress syndrome. Most authorities believe this condition, which has a mortality of up to 30%, is under-recognized.
Fluid overload
Excess or over-rapid transfusion may result in acute left ventricular failure, with signs of pulmonary oedema. The transfusion should be stopped and steps to relieve the pulmonary oedema should be given, including diuretics and oxygen. Massive blood transfusion is the acute administration of more than 1.5 times the patient's blood volume, or replacement of the patient's total blood volume within 24 hours.
Long-term hazards
Risk of infectious disease
Because of donor selection and screening techniques, the risk of transmission of infectious disease is very rare for red cell, FFP and cryoprecipitate transfusions ( Table  8) . A figure for platelet transfusions is more difficult as single platelet donors are more regularly tested, whereas platelet pools are derived from four donors.
Two cases of vCJD transmission by blood transfusion have been reported in the UK along with another of vCJD 'infectivity': the recipient died of other causes but had evidence of abnormal prion protein at post mortem.
Iron overload
Repeated transfusions for chronic anaemia, for example thalassaemia, may result in iron deposition in the tissues and organ injury. This is treated by prophylaxis with the iron binding agent desferrioxamine.
Immunosuppression
There is some evidence that transfusion around the time of surgery may be associated with a greater risk of postoperative infections and tumour recurrence in cancer patients, but this is controversial.
Alternatives to allogenic blood transfusion
The expense and side-effects of transfusion has led to the search for alternatives, some of which are clinically established and some still in development ( Table 9 ). Many of these are only appropriate for elective, planned surgery.
Social implications of blood transfusion
A blood transfusion is a procedure with potential complications: many patients would prefer not to be transfused if at all possible. Jehovah's witnesses refuse all blood products, but may allow blood to be retransfused if it has not lost contact with the circulation such as during cardiopulmonary bypass.
It is advisable to obtain and record a patient's consent for blood transfusion, especially if they may receive blood while under anaesthetic.
Conclusions
Blood transfusion is an essential part of acute medical care, but it has side effects. Modern practise emphasizes the rationalization of transfusion according to guidelines at a national and local level. Where possible, transfusion practice should be audited, and transfusion-avoidance strategies used. BJHM Table 9 . Alternatives to transfusion n Great care should be taken to ensure the correct blood reaches the right patient.
n Modern evidence suggests a transfusion trigger of haemoglobin<8 g/dl in most patients.
n Blood products components such as fresh frozen plasma and cryoprecipitate have limited indications.
n Blood use should be audited at a local and national level.
n There are many established and experimental strategies to minimize the need for transfusion.
